Our latest COVID-19 information - full Autumn programme of webinars now in place

Training courses & Webinars:

Veterinary pharmacovigilance is the on-going monitoring of the safety and efficacy of medicines used for the prevention, diagnosis and treatment of disease in animals. Our pharmacovigilance training courses will provide participants with the necessary information to comply with latest regulations.


Advanced Veterinary Pharmacovigilance Training Course

Advanced Veterinary Pharmacovigilance

25-26 Nov 2020 - Online webinar
Also on: 21 Jun 2021

Including the main requirements of Volume IXB, an update on the proposed EU Regulation (2019/6) on Veterinary Medicinal Products and the impact of Brexit

Presented by Declan O'Rourke (bio)

View details

Introduction to Veterinary Pharmacovigilance Training Course

Introduction to Veterinary Pharmacovigilance

20-21 Apr 2021 - Online webinar
Also on: 22 Apr 2021

A basic training course for those working on drug safety in the EU. This course has been designed to provide basic training and a good introduction to those concerned with veterinary pharmacovigilance.

*INCLUDES: Interactive workshop and discussion sessions*

Presented by Declan O'Rourke (bio)

View details

Periodic Safety Update Reports for Veterinary Medicinal Products Training Course

Periodic Safety Update Reports for Veterinary Medicinal Products

11-12 May 2021 - Online webinar
Also on: 13 May 2021

Including requirements for regions including the EEA, USA, Canada and Australia and an update on the implications of Brexit


Presented by Declan O'Rourke (bio)

View details

The New EU (European Union) Animal Health Legislation for Veterinary Medicinal Products Training Course

The New EU Animal Health Legislation for Veterinary Medicinal Products

11-12 Nov 2020 - Online webinar
Also on: 5 May 2021

The programme will offer a comprehensive introduction to the new EU Regulation (2019/6) and will address the changes and implications to the industry including marketing authorisations, submissions and dossiers.

*INCLUDES: Interactive discussion sessions*

Presented by Julian Braidwood (bio)

View details

I really enjoyed this course. The interactions with other participants and the flexibility of the speaker to engage in real-world scenarios helped to put the course content into perspective. It was nice to know that other companies face similar challenges, and get practical solutions and advice from the speaker.

Amanda Dwyer, Pharmacovigilance Manager, North America, Elanco Animal Heallth

The main themes of the new Regulation were presented in a precise but detailed manner and this, coupled with the extensive knowledge and sympathetic manner of the speaker, make the course something special.

Heike Luckow, Regulatory Affairs, Bela-Pharm GmbH & Co. KG

Very informative, interactive course with room for questions and discussion. I learned a lot of practical things and points to consider.

Marjolijn Verweij-Heemskerk, Junior Consultant Pharmacovigilance, DADA Consultancy BV

A good course to get a general introduction to Veterinary Pharmacovigilance, for those new to pharmacovigilance. The speaker, Declan O'Rourke, is very experienced and very enthusiastic in his presentation.

Anders Hessellund Bisgaard, QA & RA Assistant, Salfarm Danmark A/S

[The speaker was] enthusiastic, clear and easy to understand. The material was relevant and well explained.

Donal Donnelly, Clinical Veterinary Surgeon and Deputy QPPV, DONAL DONNELLY

An interesting, informative and interactive two-day course which provided a clear overview and explanation of the most important changes that we can expect as a result of the 2019/6 Legislation. It is not easy to keep the audience interested while explaining a new law but Julian managed to do this excellently.

Kitty Ruigrok, DVM, Regivet BV

In general very interesting course.

Guy Werquin, Veterinary Doctor, Versele-Laga

Good general overview about pharmacovigilance. Talented and passionate speaker. Many practical examples.

Tom Decock, Regulatory Affairs, Versele-Laga

Very good course. Personally I would have needed more time on PSURs and signal detection and less on cases assessment. Very informative and enthusiastic.

Claire Milard, Pharmacovigilance manager, Merial - Boehringer Ingelheim

Overall a good course.

Heetika Malik, QPPV, Interchemie werken "De Adelaar" B.V